Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update

Author： Anglicheau Dany   Legendre Christophe   Beaune Philippe   Thervet Eric  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.7, 2007-07, pp. : 835-849

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

“Drugs on oxygen”: an update and perspective on the role of cytochrome P450 testing in pharmacology

By Tralau Tewes   Luch Andreas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1357-1362

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 and Anticancer Drugs

By  

Current Drug Metabolism, Vol. 7, Iss. 1, 2006-01 ,pp. : 23-37

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

By Zhou Shufeng  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 279-304

Adis International

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and response to antipsychotic therapy

By Scordo Maria Gabriella   Spina Edoardo  

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 201-218

Future Medicine

Access to resources Recommend Favorite